An Interview With John MacMahon, CEO of CytoKind, on the Benefits of Artificial Sunlight

Episode 232  ·  Jul 06, 03:19 PM
Share
Subscribe

Larry Luxner, senior correspondent for Rare Disease Advisor, interviews John MacMahon, a New Hampshire-based medical devices company that specializes in phototherapy to treat fatigue in people with multiple sclerosis.